Detecting and treating cancer with nanotechnology

Nanotechnology offers many opportunities for enhanced diagnostic and therapeutic medicine against cancer and other diseases. In this review, the special properties that result from the nanoscale size of quantum dots, metal colloids, superparamagnetic iron oxide, and carbon-based nanostructures are reviewed and interpreted against a background of the structural and electronic detail that gives rise to their nanotechnologic behavior. The detection and treatment of cancer is emphasized, with special attention paid to the biologic targeting of the disease. The future of nanotechnology in cancer research and clinical practice is projected to focus on 'theranostic' nanoparticles that are both diagnostic and therapeutic by design.     

Mesoporous silicon nanotechnology for cancer applications

Abstract

The commonest genetic defects leading to α-thalassemia are genomic deletions encompassing one or both α-globin loci. The aim of this work was to evaluate the interest of melting curves characteristics obtained in gap real-time polymerase chain reaction for the diagnosis of α-thalassemia deletions. Five patients with known deletional α-thalassemia, and five control subjects were tested. The melting temperature and melting curve shapes of the PCR products allowed us to discriminate controls from α-thalassemic patients. This promising strategy should be further tested with samples carrying other α-thalassemic deletions.

Background

The commonest genetic defects leading to α-thalassemia are genomic deletions encompassing one or both α-globin loci. The aim of this work was to evaluate the interest of melting curves characteristics obtained in gap real-time polymerase chain reaction for the diagnosis of α-thalassemia deletions.

Methods

Five patients with known deletional α thalassemia, —(MED)(2), —(SEA)(2), —(FIL)(1), and five control subjects were tested. Specific primers were used for each deletion. Real-time-gap PCRs, using SYBER-Green mix, were performed on a « light-cycler 480 from Roche® ». At the melting temperature, the released of the SYBER-Green dye bonded to double strained DNA is associated with a dramatic decrease in fluorescence intensity. The rate of this variation was determined by plotting the negative derivative of fluorescence vs temperature (lightcycler 480 software, Roche®).

Results

The melting temperature (Tm) and melting curve shapes of the PCR products derived from α-thalassemic patients or control subjects, allowed us to discriminate controls from α-thalassemic patients (eg —Phil Tm = 91°C whereas control Tm = 81 and 85,6°C). Some non specific amplified products are still present, probably because of the high GC content and high homology of sequences in the α-globin cluster.

Conclusion

This promising strategy should be further tested with samples carrying other α-thalassemic deletions. Nevertheless it appears reliable, cost-effective and safe offering additional benefits including minimal labor, rapid turnaround time and decreased risk of PCR carryover contamination. It may be one alternative technology available for routine diagnosis of all types of deletional α-thalassemia.     

Current applications of nanotechnology to develop plant growth inducer agents as an innovation strategy

Abstract

Nanotechnology has been proposed as an important tool and strategy for applying new products in agriculture at the nanometer scale in order to improve the food crop at sustainability and productivity levels for contributing with the agriculture security. Nanoparticles (NPs) have been planted as an intelligent material with a large contact surface per unit mass respect to bulk-products, allowing its effect to be exerted with greater efficiency in a specific point on a plant target. Currently, NPs have been studied to be applied to various species of monocotyledonous and dicotyledonous plants. Some NPs properties such as concentration, shape, size, composition and surface functionality have the ability to regulate the NPs growth effects on the plant during germination and seedling stages under controlled and field conditions. Furthermore, several studies have tried to explain the mechanism of uptake, translocation and accumulation of NPs inside the plant at the organ and cell level, but further studies are needed to determine specific mechanisms and exact action. Nevertheless, evaluation of the toxicity effects of NPs on physiological indexes of the plant is needed to determine the effective dose without producing adverse effects on the plant and food chain. It is noteworthy that studies have indicated that nanoparticles, regardless of their nature, can be efficient inducers of plant growth. However, a series of laboratory tests are required to optimize their application conditions and their specific physiological impact on plants. In this review, we summarize the knowledge about NPs application to induce plant growth to direct future studies in order to propose NPs for technological innovation.     

Chiral nanotechnology

A review of chiral, nanoscale science and technology is presented, with the subject divided into two topics. The first discusses nanotechnology in the service of asymmetric synthesis, chiral separations, and analysis. The second topic concerns broader research in the nanotechnology realm, where molecular chirality plays a role in the properties of materials, including molecular devices, chiral supramolecules, chiral nanotubes, chiral fullerenes, and DNA nanotechnology.     

A banking strategy toward customized therapy in breast cancer

In breast cancer, various clinical parameters are assessed to define clinical stage and thus obtain a more accurate prognosis. However, banks of tumor tissues are an important source of material for studies of risk of recurrence and of features governing clinical outcome in breast cancer. Although the heterogeneous characteristics of individual tumors, subtle phenotypes and stem cells can only be identified in viable cells, tissue banks often give low priority to the preservation of living cells because it is labor-intensive and expensive. The present study was designed to evaluate the feasibility of introducing, within the routine procedures of tissue preservation, a cryopreservation protocol that allows the recovery of living cells after storage. We analyzed the effect of storage time on cell viability, growth rates, and protein expression of ten human breast cancer specimens subjected to various cryopreservation techniques. Cryopreservation of cancer tissue specimens for 12 months allowed protein characterization but not the recovery of living cells. Here we show that enzymatic digestion immediately before slow freezing, and storage in liquid nitrogen permits the recovery and expansion of living cells that can be tailored to specific requirements and projects.     

A robust meta-classification strategy for cancer detection from MS data

We propose a novel method for phenotype identification involving a stringent noise analysis and filtering procedure followed by combining the results of several machine learning tools to produce a robust predictor. We illustrate our method on SELDI-TOF MS prostate cancer data (http://home.ccr.cancer.gov/ncifdaproteomics/ppatterns.asp). Our method identified 11 proteomic biomarkers and gave significantly improved predictions over previous analyses with these data. We were able to distinguish cancer from non-cancer cases with a sensitivity of 90.31% and a specificity of 98.81%. The proposed method can be generalized to multi-phenotype prediction and other types of data (e.g., microarray data).     

Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology

Pain is experienced by most cancer patients and represents an important issue in the clinical setting. Breakthrough pain is a transitory flare of pain that occurs in most cancer patients on a background of otherwise controlled persistent pain. Treatment of breakthrough pain is a challenging phenomenon. Oral transmucosal fentanyl citrate (OTFC; Actiq, Cephalon, UK), a new opioid formulation with a unique delivery system, utilizing the advantages that nanotechnology offers, reflects the characteristics of breakthrough pain (rapid onset of action and short duration), which makes it an effective treatment to cancer patients who are already receiving opioids and continue to experience such flares of pain. Oral transmucosal fentanyl citrate is specifically developed and approved for the management of breakthrough pain in cancer patients and it has the potential to be a useful tool for clinicians.